Shinji Miyata

Dr. Shinji Miyata

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2012 in Nature Neuroscience
Verified
Journal Article
Closed access
SMShinji Miyata
Shinji Miyata
YKYukio Komatsu
Yukio Komatsu
YYYumiko Yoshimura
Yumiko Yoshimura
CTChoji Taya
Choji Taya
HKHiroshi Kitagawa
Hiroshi Kitagawa

1 October 2017 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
SMShinji Miyata
Shinji Miyata
HKHiroshi Kitagawa
Hiroshi Kitagawa

12 November 2013 in Nature Communications
Verified
Journal Article
Open access
PDF file
KTKosei Takeuchi
Kosei Takeuchi
NYNozomu Yoshioka
Nozomu Yoshioka
SOSusumu Higa Onaga
Susumu Higa Onaga
YWYumi Watanabe
Yumi Watanabe
SMShinji Miyata
Shinji Miyata
MIMichihiro Igarashi
Michihiro Igarashi
Extracellular factors that inhibit axon growth and intrinsic factors that promote it affect neural regeneration. Therapies targeting any single gene have not yet simultaneously optimized both types of factors. Chondroitin sulphate (CS), a glycosaminoglycan, is the most abundant extracellular inhibitor of axon growth. Here we show that mice carrying a gene knockout for CS N-acetylgalactosaminyltransferase-1 (T1), a key enzyme in CS biosynthesis, recover more completely from spinal cord injury than wild-type mice and even chondroitinase ABC-treated mice. Notably, synthesis of heparan sulphate (HS), a glycosaminoglycan promoting axonal growth, is also upregulated in TI knockout mice because HS-synthesis enzymes are induced in the mutant neurons. Moreover, chondroitinase ABC treatment never induces HS upregulation. Taken together, our results indicate that regulation of a single gene, T1, mediates excellent recovery from spinal cord injury by optimizing counteracting effectors of axon regeneration—an extracellular inhibitor of CS and intrinsic promoters, namely, HS-synthesis enzymes.

3 October 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
XHXubin Hou
Xubin Hou
NYNozomu Yoshioka
Nozomu Yoshioka
HTHiroaki Tsukano
Hiroaki Tsukano
ASAkiko Sakai
Akiko Sakai
SMShinji Miyata
Shinji Miyata
SSSayaka Sugiyama
Sayaka Sugiyama
Ocular dominance plasticity is easily observed during the critical period in early postnatal life. Chondroitin sulfate (CS) is the most abundant component in extracellular structures called perineuronal nets (PNNs), which surround parvalbumin-expressing interneurons (PV-cells). CS accumulates in PNNs at the critical period, but its function in earlier life is unclear. Here, we show that initiation of ocular dominance plasticity was impaired with reduced CS, using mice lacking a key CS-synthesizing enzyme, CSGalNAcT1. Two-photon in vivo imaging showed a weaker visual response of PV-cells with reduced CS compared to wild-type mice. Plasticity onset was restored by a homeoprotein Otx2, which binds the major CS-proteoglycan aggrecan and promotes its further expression. Continuous CS accumulation together with Otx2 contributed bidirectionally to both onset and offset of plasticity, and was substituted by diazepam, which enhances GABA function. Therefore, CS and Otx2 may act as common inducers of both onset and offset of the critical period by promoting PV-cell function throughout the lifetime.

14 January 2016 in Neural Plasticity
Verified
Journal Article
Open access
PDF file
SMShinji Miyata
Shinji Miyata
HKHiroshi Kitagawa
Hiroshi Kitagawa
Perineuronal nets (PNNs) are lattice-like extracellular matrix structures composed of chondroitin sulfate proteoglycans (CSPGs). The appearance of PNNs parallels the decline of neural plasticity, and disruption of PNNs reactivates neural plasticity in the adult brain. We previously reported that sulfation patterns of chondroitin sulfate (CS) chains on CSPGs influenced the formation of PNNs and neural plasticity. However, the mechanism of PNN formation regulated by CS sulfation remains unknown. Here we found that overexpression of chondroitin 6-sulfotransferase-1 (C6ST-1), which catalyzes 6-sulfation of CS chains, selectively decreased aggrecan, a major CSPG in PNNs, in the aged brain without affecting other PNN components. Both diffuse and PNN-associated aggrecans were reduced by overexpression of C6ST-1. C6ST-1 increased 6-sulfation in both the repeating disaccharide region and linkage region of CS chains. Overexpression of 6-sulfation primarily impaired accumulation of aggrecan in PNNs, whereas condensation of other PNN components was not affected. Finally, we found that increased 6-sulfation accelerated proteolysis of aggrecan by a disintegrin and metalloproteinase domain with thrombospondin motif (ADAMTS) protease. Taken together, our results indicate that sulfation patterns of CS chains on aggrecan influenced the stability of the CSPG, thereby regulating formation of PNNs and neural plasticity.

6 November 2014 in The Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
SMShinji Miyata
Shinji Miyata
HKHiroshi Kitagawa
Hiroshi Kitagawa
Chondroitin sulfate proteoglycans (CSPGs), consisting of core proteins linked to one or more chondroitin sulfate (CS) chains, are major extracellular matrix (ECM) components of the central nervous system (CNS). Multi-functionality of CSPGs can be explained by the diversity in structure of CS chains that undergo dynamic changes during development and under pathological conditions. CSPGs, together with other ECM components, form mesh-like structures called perineuronal nets around a subset of neurons. Enzymatic digestion or genetic manipulation of CSPGs reactivates neural plasticity in the adult brain and improves regeneration of damaged axons after CNS injury. Recent studies have shown that CSPGs not only act as non-specific physical barriers that prevent rearrangement of synaptic connections, but also regulate neural plasticity through specific interaction of CS chains with its binding partners in a manner that depends on the structure of the CS chain.